Document is current
Any future updates will be listed below
-
Authors
Ikoma, Tatsuki http://orcid.org/0000-0003-3758-3425
Shimokawa, Mototsugu
Kotaka, Masahito
Matsumoto, Toshihiko
Nagai, Hiroki
Boku, Shogen
Shibata, Nobuhiro
Yasui, Hisateru
Satake, Hironaga
- License Information
-
More Information
Article History
Received: 1 March 2021
Accepted: 26 April 2021
First Online: 7 May 2021
Declarations
:
: This study was carried out in accordance with the Helsinki Declaration and Ethical Guidelines for Clinical Studies and was approved by the institutional review boards of all three participating hospitals, Kobe City Medical Center General Hospital, Kansai Medical University Hospital, and Sano Hospital. Written informed consent was obtained from all the participating patients before entering the study.
: Not applicable.
: HS has received research funding from Ono Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and honoraria from Bayer, Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo, Eli Lilly Japan, Merck Bio Pharma, MSD, Ono Pharmaceutical, Sanofi, Taiho Pharmaceutical Co., Ltd., Takeda, and Yakult Honsha.MK has received honoraria from Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Yakult, Taiho Pharma, and Merck Biopharma Co., Ltd.The other physicians have no COI.
